The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory

Yuan Li, Zhijun Yao, Yue Yu, Yu Fu, Ying Zou, Bin Hu, for the Alzheimer’s Disease Neuroimaging InitiativeFrontiers in Aging Neuroscience 2019 · DOI

TL;DR

This study investigates how genetic predisposition (APOE ε4) and cerebrospinal fluid (CSF) tau levels influence the spread and network organization of PHF-tau protein in the brain, a key marker for Alzheimer's disease (AD). They found that both APOE ε4 and abnormal CSF tau contribute to altered PHF-tau distribution and network properties, with APOE ε4 having a more pronounced effect, offering insights into the early stages of cognitive decline.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is a devastating neurodegenerative condition, and mild cognitive impairment (MCI) is often a precursor. A critical protein implicated in AD pathogenesis is tau, specifically in its paired helical filament (PHF-tau) form, which aggregates into neurofibrillary tangles. While we know PHF-tau accumulation disrupts brain function and structure, our understanding of how these disruptions manifest as a network phenomenon in MCI, especially considering common risk factors, is limited. This paper aims to bridge this gap by examining the influence of two major risk factors – the Apolipoprotein E ε4 (APOE ε4) gene and abnormal cerebrospinal fluid Total-tau (CSF T-tau) levels – on the brain's PHF-tau network in individuals with MCI.

Methods

The researchers employed a multi-faceted approach combining neuroimaging and graph theory. They utilized Positron Emission Tomography (PET) imaging with the radiotracer 18F-AV-1451 to visualize PHF-tau distribution in the brain. To analyze the brain's structural organization, they applied graph theory, treating brain regions as nodes and connections (based on PHF-tau correlation) as edges. This allowed them to calculate various network properties:

  • Global Network Properties:
    • Clustering Coefficient (Cp): Measures how interconnected a node's neighbors are, indicating local network density.
  • Characteristic Path Length (Lp): Represents the average shortest path between any two nodes, reflecting information transfer efficiency.
  • Modularity (Q): Assesses the network's ability to be divided into distinct communities or modules.
  • Nodal Properties:
    • Betweenness Centrality (BC): Identifies nodes that lie on many shortest paths between other nodes, acting as critical bridges.
  • Degree: The number of connections a node has, indicating its direct involvement in the network.

They also performed voxel-level analysis to pinpoint specific brain regions with altered PHF-tau distribution and used Pearson correlation to link these regional changes to cognitive function as measured by the Functional Assessment Questionnaire (FAQ).

Datasets

The study utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. This publicly available dataset includes PET, MRI, and CSF measurements from 225 participants diagnosed with MCI or classified as normal controls.

Key Insights and Ideas

  • Synergistic Impact of Risk Factors: The study highlights that both APOE ε4 and abnormal CSF T-tau contribute to PHF-tau pathology, but their combined effects on brain networks are complex and not simply additive.
  • APOE ε4 as a "Super-Spreader": The findings suggest that APOE ε4 plays a more significant role in the spread and network disruption caused by PHF-tau compared to CSF T-tau alone. This implies that APOE ε4 might facilitate the propagation of tau pathology across brain regions.
  • Network Disruption in Early Stages: Even in MCI, significant alterations in brain network topology are observable, indicating that these changes precede overt dementia and can be detected through PHF-tau imaging and graph theory analysis.
  • Cognitive Link: The positive correlation between PHF-tau distribution in specific brain regions and FAQ scores in the APOE ε4-positive, high-tau group underscores the functional consequence of tau pathology on cognitive function.

Key Results

  • PHF-Tau Distribution: Compared to the control group (APOE 4-T-), all other three groups (APOE 4+T+, APOE 4+T-, APOE 4-T+) showed increased PHF-tau distribution in various brain regions. The APOE 4+T+ group exhibited the most widespread increases.
  • Network Properties: Significant differences in clustering coefficient, characteristic path length, and modularity were observed across the groups. Generally, the abnormal groups showed altered network integration and segregation compared to the control group.
  • Nodal Properties: Significant differences in nodal centrality and degree were found in specific brain regions across the groups, indicating that certain brain areas are more vulnerable to the influence of APOE ε4 and CSF T-tau on PHF-tau pathology.
  • Correlation with Cognition: In the APOE 4+T+ group, increased PHF-tau distribution in altered regions was positively correlated with higher FAQ scores, suggesting a link between tau pathology and cognitive impairment severity.

Limitations and Future Work

The authors acknowledge a few limitations:

  • Moderating Variables: Average education years and intelligence quotient were not collected, which could influence cognitive performance and brain network analysis.
  • AD Cohort Exclusion: The study focused on MCI patients and did not include individuals with diagnosed AD, limiting the ability to fully understand the progression from MCI to AD.
  • Tau Tracer Specificity: The AV-1451 PET tracer primarily detects aggregated tau in tangles and may not fully capture other forms of tau pathology, such as oligomeric tau.

Future work could expand on these findings by including AD patients to track disease progression, incorporating additional demographic and cognitive variables, and exploring the role of different tau species. The study's findings provide a strong foundation for further research into the complex interplay of genetic and fluid biomarkers in the development of AD.

Summary updated

Abstract

Mild cognitive impairment (MCI) is a transitional state between the cognitive changes in normal aging and Alzheimer's disease (AD), which induces abnormalities in specific brain regions. Previous studies showed that paired helical filaments Tau (PHF-Tau) protein is a potential pathogenic protein which may cause abnormal brain function and structure in MCI and AD patients. However, the understanding of the PHF-Tau protein network in MCI patients is limited. In this study, 225 subjects with PHF-Tau Positron Emission Tomography (PET) images were divided into four groups based on whether they carried Apolipoprotein E ε4 (APOE 4) or abnormal cerebrospinal fluid Total-Tau (CSF T-Tau). They are two important pathogenic factors that might cause cognitive function impairment. The four groups were: individuals harboring CSF T-Tau pathology but no APOE 4 (APOE 4-T+); APOE 4 carriers with normal CSF T-Tau (APOE 4+T-); APOE 4 carriers with abnormal CSF T-Tau (APOE 4+T+); and APOE 4 noncarriers with abnormal CSF T-Tau (APOE 4-T-). We explored the topological organization of PHF-Tau networks in these four groups and calculated five kinds of network properties: clustering coefficient, shortest path length, <i>Q</i> value of modularity, nodal centrality and degree. Our findings showed that compared with APOE 4-T- group, the other three groups showed different alterations in the clustering coefficient, shortest path length, <i>Q</i> value of modularity, nodal centrality and degree. Simultaneously, voxel-level analysis was conducted and the results showed that compared with APOE 4-T- group, the other three groups were found increased PHF-Tau distribution in some brain regions. For APOE 4+T+ group, positive correlation was found between the value of PHF-Tau distribution in altered regions and Functional Assessment Questionnaire (FAQ) score. Our results indicated that the effects of APOE 4 and abnormal CSF T-Tau may induce abnormalities of PHF-Tau protein and APOE 4 has a greater impact on PHF-Tau than abnormal CSF T-Tau. Our results may be particularly helpful in uncovering the pathophysiology underlying the cognitive dysfunction in MCI patients.
BibTeX
@inproceedings{li2019influence,
  author = {Yuan Li and Zhijun Yao and Yue Yu and Yu Fu and Ying Zou and Bin Hu and for the Alzheimer’s Disease Neuroimaging Initiative},
  title = {{The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory}},
  booktitle = {Frontiers in Aging Neuroscience},
  year = {2019},
  doi = {10.3389/fnagi.2019.00208},
}
Figure